ARCHIVES

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

This article is from The Cancer Letter archive.

Vol. 03 No. 08 | February 25, 1977

Download PDF Visit The Full Archive

Related Articles

Expanded Tissue Resources, Equipment Funds Planned.

December 8, 2000

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992

FDA News: Clinton Nominates Jane Henney For FDA Commissioner

June 26, 1998

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

May 2, 2008

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004